SIC
GOSS icon

Salem Investment Counselors’s Gossamer Bio GOSS Stock Holding History

Salem Investment Counselors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-100
Closed -$120 – 1137
2023
Q2 		$120 Hold
100
– – ﹤0.01% 1123
2023
Q1 		$126 Hold
100
– – ﹤0.01% 1092
2022
Q4 		$217 Hold
100
– – ﹤0.01% 1048
2022
Q3 		$1K Hold
100
– – ﹤0.01% 989
2022
Q2 		$1K Hold
100
– – ﹤0.01% 1020
2022
Q1 		$1K Hold
100
– – ﹤0.01% 963
2021
Q4 		$1K Hold
100
– – ﹤0.01% 1036
2021
Q3 		$1K Hold
100
– – ﹤0.01% 938
2021
Q2 		$1K Buy
+100
New +$867 ﹤0.01% 865

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Salem Investment Counselors's GOSS Position: Q3 2023 in Review

Salem Investment Counselors sold out of Gossamer Bio (GOSS) in Q3 2023, closing a stake of 100 shares — an estimated $120 sold.

Salem Investment Counselors first reported a position in GOSS in Q2 2021 and held it in 9 quarters. The position peaked at $1K in Q3 2022. 95 funds tracked by Wall St. Rank hold GOSS as of Q3 2023.

  • Salem Investment Counselors reported no remaining Gossamer Bio position as of Q3 2023 after selling out during the quarter.
  • Salem Investment Counselors sold 100 Gossamer Bio shares in Q3 2023, an estimated $120.
  • Salem Investment Counselors first reported a position in Gossamer Bio in Q2 2021 and held it in 9 quarters.
  • Salem Investment Counselors's Gossamer Bio position peaked at $1K in Q3 2022.
  • 95 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2023.

Based on Salem Investment Counselors's 13F filing for Q3 2023, filed 4 Oct 2023.